Gotowe bibliografie tematyczne / Neridronic acid / Artykuły w czasopismach
Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Neridronic acid.

Artykuły w czasopismach na temat „Neridronic acid”

Autor: Grafiati
Data publikacji: 2 czerwca 2025
Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 15 najlepszych artykułów w czasopismach naukowych na temat „Neridronic acid”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

&NA;. "Neridronic acid." Reactions Weekly &NA;, no. 1309 (2010): 30. http://dx.doi.org/10.2165/00128415-201013090-00097.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Mollaamin, Fatemeh, and Majid Monajjemi. "Application of DFT/TD-DFT Frameworks in the Drug Delivery Mechanism: Investigation of Chelated Bisphosphonate with Transition Metal Cations in Bone Treatment." Chemistry 5, no. 1 (2023): 365–80. http://dx.doi.org/10.3390/chemistry5010027.

Pełny tekst źródła
Streszczenie:
Carbon nanotubes (CNTs) are applied in a drug delivery system, which can be reacted with different structures such biomolecules. Bones have vital functions and are the locations of biochemical reactions in cells that might be exposed various diseases. As different metal ions are integral components of bone tissue with different functions in the physiological cellular medium as well as in bone treatment, they can be used differently as a basis or as a supplement for various materials in the field of bone repair. Therefore, this research aims to represent the recent progress in conjugated bispho
Style APA, Harvard, Vancouver, ISO itp.
3

&NA;. "Neridronic acid is effective in treating malignant hypercalcaemia." Inpharma Weekly &NA;, no. 941 (1994): 11. http://dx.doi.org/10.2165/00128413-199409410-00019.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Galantsev, A. V., D. V. Drobot, P. V. Dorovatovsky, and V. N. Khrustalev. "Lanthanum Complex with Neridronic Acid: Synthesis and Properties." Fine Chemical Technologies 14, no. 2 (2019): 70–77. http://dx.doi.org/10.32362/2410-6593-2019-14-2-70-77.

Pełny tekst źródła
Streszczenie:
Currently, various amino bisphosphonates are widely used in the treatment of many bone diseases. One of the most well-known complex compounds of neridronic acid (6-amino-1-hydroxyhexylidene-1,1- bisphosphonic acid) is sodium neridronate – a bisphosphonate, which is used to treat osteogenesis and Paget's disease. However, there is no data on compounds of neridronic acid with rare earth elements. A new complex of lanthanum with 6-amino-1-hydroxyhexylidene-1,1-bisphosphonic acid (I) was obtained and characterized by various physicochemical methods (chemical analysis, IR spectroscopy, solid-phase
Style APA, Harvard, Vancouver, ISO itp.
5

Gatti, Davide, Ombretta Viapiana, Luca Idolazzi, Elena Fracassi, and Silvano Adami. "Neridronic acid for the treatment of bone metabolic diseases." Expert Opinion on Drug Metabolism & Toxicology 5, no. 10 (2009): 1305–11. http://dx.doi.org/10.1517/17425250903029190.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Aderibigbe, B. A., E. R. Sadiku, S. Sinha Ray, et al. "Synthesis and characterization of polyamidoamine conjugates of neridronic acid." Polymer Bulletin 72, no. 3 (2014): 417–39. http://dx.doi.org/10.1007/s00289-014-1286-z.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Nicolin, Vanessa, Renato Bareggi, Giovanna Baldini, Roberta Bortul, Bruno Martinelli, and Paola Narducci. "Effects of neridronic acid on osteoclasts derived by physiological dual-cell cultures." Acta Histochemica 109, no. 5 (2007): 397–402. http://dx.doi.org/10.1016/j.acthis.2007.04.002.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Nicolin, V., P. Narducci, and B. Martinelli. "Neridronic acid directly regulates osteoblast proliferation and gene expression in human osteoblast cell line." Bone 44 (June 2009): S448. http://dx.doi.org/10.1016/j.bone.2009.03.420.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Lurati, A. "Efficacy of Neridronic Acid IV and IM in Improving BMD and Reducing Fracture Risk in Postmenopausal Osteoporosis." International Journal of Biochemistry Research & Review 3, no. 3 (2013): 259–65. http://dx.doi.org/10.9734/ijbcrr/2013/4210.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Fornari, Rachele. "Metabolic Characterization and Follow up of Adult Patients Affected by Osteogenesis Imperfecta in Long-term Treatment with Neridronic Acid." British Journal of Medicine and Medical Research 1, no. 4 (2011): 478–85. http://dx.doi.org/10.9734/bjmmr/2011/501.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
11

"Neridronic acid." Reactions Weekly 1704, no. 1 (2018): 278. http://dx.doi.org/10.1007/s40278-018-46921-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

"Neridronic-acid." Reactions Weekly 1931, no. 1 (2022): 464. http://dx.doi.org/10.1007/s40278-022-27261-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Fornari, Rachele, Paolo Sgro, Emanuela Greco, et al. "Metabolic Characterization and Follow up of Adult Patients Affected by Osteogenesis Imperfecta in Long-term Treatment with Neridronic Acid." September 23, 2011. https://doi.org/10.5281/zenodo.7798.

Pełny tekst źródła
Streszczenie:
Aims: Osteogenesis imperfecta (OI) is a rare inherited disorder causing low bone density and increased fragility. Bisphosphonates (BP) are a treatment of choice for OI. Few studies have investigated the long-term effects of BP in OI patients. Thus, aim of our study was to follow up adults affected by OI to evaluate changes in metabolic, clinical situation and safety of long-term neridronic acid therapy, BP authorized for OI treatment. Study design: Longitudinal observational study. Place and duration of the Study: Department of Experimental Medicine, Section of Medical Pathophysiology, Endocri
Style APA, Harvard, Vancouver, ISO itp.
14

Borrelli, Angela Carla, Laura Capozzi, Massimiliano De Vivo, et al. "Treatment with Neridronic Acid in a Newborn with Severe and Refractory Hypercalcemia Associated with Subcutaneous Fat Necrosis." Journal of Neonatology, May 10, 2023, 097321792311662. http://dx.doi.org/10.1177/09732179231166280.

Pełny tekst źródła
Streszczenie:
Neonatal subcutaneous fat necrosis (SCFN) is a transient, generally benign panniculitis that presents within several weeks of life and occurs mostly in term or post-term newborns who have a history of intrauterine or perinatal distress. It is usually a self-limited condition. Hypercalcemia is a rare but serious complication of SCFN and needs prolonged follow-up. The etiopathogenesis of both subcutaneous fat necrosis in newborn and the resultant hypercalcemia is poorly understood. We describe a classic presentation of SCFN that led to a severe hypercalcemia refractory to standard treatment. Thi
Style APA, Harvard, Vancouver, ISO itp.
15

"EYE ON CHINA." Asia-Pacific Biotech News 18, no. 07 (2014): 17–23. http://dx.doi.org/10.1142/s0219030314000469.

Pełny tekst źródła
Streszczenie:
ScinoPharm and Lee's Pharmaceutical jointly develop drug products for the Chinese market. WuXi PharmaTech begins construction of new R&D and cGMP manufacturing campus in Changzhou. NeoStem signs Licensing Agreement with Cellular Biomedicine Group and plans to begin Phase 2 hepatocellular carcinoma trial in China. Abiogen Pharma signed agreement with Lee's Pharma to market Neridronic Acid in mainland China, Taiwan, Hong Kong and Macau. InSightec launches its first centers in China. Shuwen Biotech and DiagnoCure sign exclusive agreement for commercializing colorectal cancer staging test in C
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii